National Institute for Health and Care Excellence

Published guidance, NICE advice and quality standards

Chronic heart failure in adults: diagnosis and management NG106 12 September 2018 3 September 2025 ...
National Institute for Health and Care Excellence

Isatuximab in combination for untreated multiple myeloma when a stem cell transplant is unsuitable

There is a simple discount patient access scheme for isatuximab. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisations can contact GB-PatientAccess ...
The National Institute for Health and Care Excellence

Our first guideline on kidney cancer recommends better use of biopsies to avoid surgery

The NICE guideline recommends offering a biopsy to help confirm the diagnosis and inform treatment options for people with suspected renal cell carcinoma (RCC), where the cancer has not spread (known ...
The National Institute for Health and Care Excellence

Hundreds of people set to benefit after life-extending lung cancer treatment given green light

Targeted immunotherapy found to significantly increase overall survival rates for people with an aggressive form of lung cancer has been recommended by NICE. People with an aggressive form of lung ...
National Institute for Health and Care Excellence

Antimicrobial stewardship

Critical assessment of evidence to help you make decisions. Advice, rather than formal NICE guidance. We've worked with Public Health England (PHE) to bring together our information on managing ...
National Institute for Health and Care Excellence

Published: Guidance, quality standards and advice

Pembrolizumab with carboplatin and paclitaxel for untreated primary advanced or recurrent endometrial cancer TA1092 27 August 2025 27 August 2025 Tarlatamab for extensive-stage small-cell lung cancer ...